These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 37242781

  • 1. Thermodynamic Modeling of the Amorphous Solid Dispersion-Water Interfacial Layer and Its Impact on the Release Mechanism.
    Dohrn S, Kyeremateng SO, Bochmann E, Sobich E, Wahl A, Liepold B, Sadowski G, Degenhardt M.
    Pharmaceutics; 2023 May 19; 15(5):. PubMed ID: 37242781
    [Abstract] [Full Text] [Related]

  • 2. Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions.
    Lehmkemper K, Kyeremateng SO, Degenhardt M, Sadowski G.
    Pharm Res; 2018 Jan 05; 35(1):25. PubMed ID: 29305717
    [Abstract] [Full Text] [Related]

  • 3. Long-Term Physical Stability of PVP- and PVPVA-Amorphous Solid Dispersions.
    Lehmkemper K, Kyeremateng SO, Heinzerling O, Degenhardt M, Sadowski G.
    Mol Pharm; 2017 Jan 03; 14(1):157-171. PubMed ID: 28043133
    [Abstract] [Full Text] [Related]

  • 4. Solvent influence on the phase behavior and glass transition of Amorphous Solid Dispersions.
    Dohrn S, Luebbert C, Lehmkemper K, Kyeremateng SO, Degenhardt M, Sadowski G.
    Eur J Pharm Biopharm; 2021 Jan 03; 158():132-142. PubMed ID: 33212185
    [Abstract] [Full Text] [Related]

  • 5. Physical stability of API/polymer-blend amorphous solid dispersions.
    Lehmkemper K, Kyeremateng SO, Bartels M, Degenhardt M, Sadowski G.
    Eur J Pharm Biopharm; 2018 Mar 03; 124():147-157. PubMed ID: 29269154
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influence of humidity on the phase behavior of API/polymer formulations.
    Prudic A, Ji Y, Luebbert C, Sadowski G.
    Eur J Pharm Biopharm; 2015 Aug 03; 94():352-62. PubMed ID: 26117187
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Phase behavior of pharmaceutically relevant polymer/solvent mixtures.
    Dohrn S, Luebbert C, Lehmkemper K, Kyeremateng SO, Degenhardt M, Sadowski G.
    Int J Pharm; 2020 Mar 15; 577():119065. PubMed ID: 31988034
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Factors Influencing the Crystallization-Onset Time of Metastable ASDs.
    Wolbert F, Fahrig IK, Gottschalk T, Luebbert C, Thommes M, Sadowski G.
    Pharmaceutics; 2022 Jan 23; 14(2):. PubMed ID: 35214002
    [Abstract] [Full Text] [Related]

  • 16. Can Pure Predictions of Activity Coefficients from PC-SAFT Assist Drug-Polymer Compatibility Screening?
    Pavliš J, Mathers A, Fulem M, Klajmon M.
    Mol Pharm; 2023 Aug 07; 20(8):3960-3974. PubMed ID: 37386723
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Congruent release of drug and polymer: A "sweet spot" in the dissolution of amorphous solid dispersions.
    Saboo S, Mugheirbi NA, Zemlyanov DY, Kestur US, Taylor LS.
    J Control Release; 2019 Mar 28; 298():68-82. PubMed ID: 30731151
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The step-wise dissolution method: An efficient DSC-based protocol for verification of predicted API-polymer compatibility.
    Mathers A, Pechar M, Hassouna F, Fulem M.
    Int J Pharm; 2023 Dec 15; 648():123604. PubMed ID: 37981251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.